Exciting that we have another new target that Recce are excited about! Let's add to the list of indications that have been announced and tested over the years:
- burns
- h pylori
- sepsis
- uro sepsis
- COVID
- mycobacterium
- hamsters
- sinus infections
- influenza
But now, it's LUNG INFECTIONS we're excited about! Forget those other things, lung infections are what we're all about now.
[INTERVIEW] Recce Pharmaceuticals accelerates commercialisation with positive Phase II results, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 29.5¢ | $2.899K | 9.826K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 88074 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 6174 | 1 |
View Market Depth
| Last trade - 09.59am 23/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |